HOME >> BIOLOGY >> NEWS
Breast implants not associated with cancer risk, study reports

Having breast implants is not associated with an increased risk of cancer overall, a new study reports in the April 19 issue of the Journal of the National Cancer Institute. Implants were associated with a decrease in breast cancer risk and an increased lung cancer risk, but these results likely reflect the lifestyles and smoking habits of the women in the study rather than an effect of the implants themselves, the authors conclude.

Past reports have examined the association between cosmetic breast implants and cancer risk, particularly breast cancer risk, but no consistent associations have been found. However, few studies have examined this association after more than 15 years.

Joseph K. McLaughlin, Ph.D., of the International Epidemiology Institute in Rockville, Md., and Vanderbilt-Ingram Cancer Center in Nashville, and colleagues examined the incidence of cancer in a nationwide cohort of 3486 Swedish women who underwent cosmetic surgery for breast implants between 1965 and 1993 and were followed until the end of 2002. Data was obtained from the Swedish Cancer Registry, which reports on cancer occurrence for the entire country. The average follow-up time was 18.4 years. The study is the longest follow-up study on cosmetic breast implants and risk of cancer incidence to date.

The authors identified 180 cancers in women with breast implants, fewer than the 193.1 predicted to occur in this population. Cosmetic implants were not associated with an increased risk of cancer overall. Women with implants had an increased incidence of lung cancer (20 cases observed, 9.1 cases expected) and a decreased incidence of breast cancer (53 cases observed, 71.9 cases expected) compared with the general population.

The authors suggest the higher incidence of lung cancer may be due to the high rates of smoking in Swedish women with cosmetic breast implants. Lower breast cancer incidence could be explained by the lower body mass index, highe
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
18-Apr-2006


Page: 1 2

Related biology news :

1. Breast cancer and hormone therapy -- A looking-glass mirror?
2. Breast cancer prognosis runs in the family
3. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
4. Is bigger better? Breast surgery linked to boost in self-esteem and sexuality
5. Breast cancer treatment heats up
6. Genesearch Breast Lymph Node assay detects breast cancer metastases with greater sensitivity
7. Breast Cancer Month story tips from Georgetown University Medical Center
8. Breast density helps predict breast cancer risk
9. Breast stem cells have features similar to basal tumors
10. Breast cancer genetics and more -- press release from PLoS Medicine
11. Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... 01, 2020 , ... Catalent, a global leader in clinical ... packaging facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating ... the new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance and ... successful study, while protecting and accessing the catheter or device post-surgery is often undervalued ... Envigo in a live webinar on Wednesday, August 5, 2020 at ...
(Date:7/18/2020)... ... 2020 , ... dicentra , a leading Contract Research ... is pleased to announce that Charles Galea has joined its clinical trials division ... an accomplished and results-driven sales executive with over 10 years of expertise in ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most ... used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate ... Dr MA has been using the zebrafish model to investigate the causes of ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
Breaking Biology Technology:
Cached News: